GMO Capital Investment Solutions Fund, L.P.

The absence of prior filings combined with a 06b exemption (pre-existing relationships only) tells allocators this manager is building from a closed network rather than pursuing broad market distribution, which constrains LP reach but also suggests the raise is anchored to existing commitments or a known investor base that does not require public marketing.

Filing in May 2026 aligns with Q2 capital deployment cycles when LPs finalize annual allocation decisions; for a $350M hedge fund target this timing is conventional, though allocators should clarify whether this raise was triggered by market dislocation, strategy vindication, or simply calendar-based LP planning.

Before engagement, verify the key-man structure across the eight named GPs—specifically whether any single GP carries a disproportionate allocation of the fund's capital or decision rights, and confirm whether this amendment modified carry, fee, or operational terms from an earlier draft that may not be publicly visible.